JPMORGAN CHASE & CO - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 66 filers reported holding SOLENO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$094
-94.1%
0.00%
Q1 2022$01,601
+1603.2%
0.00%
Q4 2021$094
-1.1%
0.00%
Q3 2021$0
-100.0%
95
-96.9%
0.00%
Q2 2021$3,000
-98.6%
3,020
-98.2%
0.00%
Q1 2021$209,000
-31.5%
166,072
+5.2%
0.00%
Q4 2020$305,000
+254.7%
157,806
+278.7%
0.00%
Q3 2020$86,000
+41.0%
41,671
+50.9%
0.00%
Q2 2020$61,000
+2950.0%
27,615
+2968.3%
0.00%
Q4 2017$2,0009000.00%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$22,769,0006.37%
CVI Holdings, LLC 1,550,960$3,443,0001.28%
ORACLE INVESTMENT MANAGEMENT INC 3,670,384$8,148,0001.03%
Trellus Management Company, LLC 366,432$813,0000.88%
AWM Investment Company, Inc. 1,550,000$3,441,0000.60%
Samsara BioCapital, LLC 750,000$1,665,0000.54%
Nantahala Capital Management 7,426,368$16,487,0000.50%
Consonance Capital Management LP 3,040,000$6,749,0000.40%
SPHERA FUNDS MANAGEMENT LTD. 1,233,676$2,739,0000.26%
Granite Point Capital Management, L.P. 2,200,000$4,884,0000.25%
View complete list of SOLENO THERAPEUTICS INC shareholders